Jielin Zhou1, Yao Lu2, Sufang Wang3, Keyang Chen4. 1. Nutrition and Food Hygiene, School of Public Health, Anhui Medical University, Hefei, Anhui, People's Republic of China. 2. Department of Anesthesiology, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, People's Republic of China. 3. Nutrition and Food Hygiene, School of Public Health, Anhui Medical University, Hefei, Anhui, People's Republic of China. wangsufangdev@126.com. 4. Nutrition and Food Hygiene, School of Public Health, Anhui Medical University, Hefei, Anhui, People's Republic of China. chenkeyang@ahmu.edu.cn.
Abstract
BACKGROUND AND AIMS: The relationship between serum amyloid A (SAA) and coronary heart disease (CHD) remains inconsistent, and the correlation of SAA levels and some factors have not been thoroughly evaluated in CHD. The present study assessed the associations of SAA levels and CHD, and the correlation of SAA levels and CRP, fibrinogen, interleukin-6 (IL-6), and HDL-C levels in CHD patient. METHODS: We systematically searched databases of Cochrane Library, PubMed, Embase, and ScienceDirect from their inception to 2018. Pooled standardized mean difference (SMD), correlation coefficient (r), and 95% confidence intervals (CI) were computed using random-effect model. RESULT: A total of 26 studies were identified for analysis, involving a total of 6466 CHD cases and 16,184 participants. Compared with the control group, the case group had markedly higher SAA levels (SMD = 0.38, 95% CI 0.21, 0.56). Subgroup analysis manifested that SAA level difference between case group and control group were associated with age, continent, and study type. Moreover, meta-regression model suggested that different continent, sex, and publication year can explain the origin of 52.05%, 50.17%, 28.07% heterogeneity, respectively. By stratified analyses, we further found that the concentration of SAA increased gradually with the aggravation of CHD. Additionally, the meta-analysis of correlation showed that SAA levels were positively related with CRP (r = 0.45, 95% CI 0.19, 0.71), fibrinogen (r = 0.41, 95% CI 0.35, 0.47), and IL-6 (r = 0.48, 95% CI 0.41, 0.54) levels, but negatively linked with HDL-C levels (r = - 0.28, 95% CI - 0.38, - 0.18) in CHD patients. CONCLUSION: High levels of SAA are significantly associated with increased risk of CHD, especially for participants aged more than 55 years, subjects from Europe and Asia, or case-control study. Furthermore, we find that SAA concentrations increased with the severity of CHD. Importantly, our study suggests that high levels of SAA might play a role in CHD by increasing CRP, fibrinogen, IL-6 levels, or attenuating HDL-C levels.
BACKGROUND AND AIMS: The relationship between serum amyloid A (SAA) and coronary heart disease (CHD) remains inconsistent, and the correlation of SAA levels and some factors have not been thoroughly evaluated in CHD. The present study assessed the associations of SAA levels and CHD, and the correlation of SAA levels and CRP, fibrinogen, interleukin-6 (IL-6), and HDL-C levels in CHDpatient. METHODS: We systematically searched databases of Cochrane Library, PubMed, Embase, and ScienceDirect from their inception to 2018. Pooled standardized mean difference (SMD), correlation coefficient (r), and 95% confidence intervals (CI) were computed using random-effect model. RESULT: A total of 26 studies were identified for analysis, involving a total of 6466 CHD cases and 16,184 participants. Compared with the control group, the case group had markedly higher SAA levels (SMD = 0.38, 95% CI 0.21, 0.56). Subgroup analysis manifested that SAA level difference between case group and control group were associated with age, continent, and study type. Moreover, meta-regression model suggested that different continent, sex, and publication year can explain the origin of 52.05%, 50.17%, 28.07% heterogeneity, respectively. By stratified analyses, we further found that the concentration of SAA increased gradually with the aggravation of CHD. Additionally, the meta-analysis of correlation showed that SAA levels were positively related with CRP (r = 0.45, 95% CI 0.19, 0.71), fibrinogen (r = 0.41, 95% CI 0.35, 0.47), and IL-6 (r = 0.48, 95% CI 0.41, 0.54) levels, but negatively linked with HDL-C levels (r = - 0.28, 95% CI - 0.38, - 0.18) in CHDpatients. CONCLUSION: High levels of SAA are significantly associated with increased risk of CHD, especially for participants aged more than 55 years, subjects from Europe and Asia, or case-control study. Furthermore, we find that SAA concentrations increased with the severity of CHD. Importantly, our study suggests that high levels of SAA might play a role in CHD by increasing CRP, fibrinogen, IL-6 levels, or attenuating HDL-C levels.
Authors: Tsuyoshi Chiba; Chang Yeop Han; Tomas Vaisar; Kentaro Shimokado; Atil Kargi; Mei-Hsiu Chen; Shari Wang; Thomas O McDonald; Kevin D O'Brien; Jay W Heinecke; Alan Chait Journal: J Lipid Res Date: 2009-03-12 Impact factor: 5.922
Authors: Mustafa Bulut; Nursen Keles; Zuhal Caliskan; Osman Kostek; Feyza Aksu; Kamil Ozdil; Mustafa Akcakoyun; Kenan Demircioglu; Yusuf Yilmaz; Mehmet Kanbay; Mustafa Caliskan Journal: Atherosclerosis Date: 2016-05-27 Impact factor: 5.162
Authors: Katariina Nurmi; Katri Niemi; Ilona Kareinen; Kristiina Silventoinen; Martina B Lorey; Yan Chen; Vesa-Petteri Kouri; Jukka Parantainen; Timo Juutilainen; Katariina Öörni; Petri T Kovanen; Dan Nordström; Sampsa Matikainen; Kari K Eklund Journal: Clin Transl Immunology Date: 2021-08-03